Does CABAZITAXEL Cause Disease progression? 143 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Disease progression have been filed in association with CABAZITAXEL (Jevtana). This represents 5.6% of all adverse event reports for CABAZITAXEL.
143
Reports of Disease progression with CABAZITAXEL
5.6%
of all CABAZITAXEL reports
46
Deaths
27
Hospitalizations
How Dangerous Is Disease progression From CABAZITAXEL?
Of the 143 reports, 46 (32.2%) resulted in death, 27 (18.9%) required hospitalization, and 3 (2.1%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for CABAZITAXEL.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
Dyspnoea (113)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which CABAZITAXEL Alternatives Have Lower Disease progression Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE